Status and phase
Conditions
Treatments
About
To evaluate the safety and preliminary efficacy of human umbilical cord mesenchymal stem cell-derived small extracellular vesicles hUC-MSC-sEV-001 nasal drops in multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple system atrophy, Lewy body dementia, frontotemporal dementia, and amyotrophic lateral sclerosis.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
General Criteria:
Inclusion Criteria:
Exclusion Criteria:
Alzheimer's Disease (AD) Specific Criteria:
Inclusion Criteria:
Exclusion Criteria:
Parkinson's Disease (PD) Specific Criteria:
Inclusion Criteria:
Exclusion Criteria:
Multiple System Atrophy (MSA) Specific Criteria:
Inclusion Criteria:
Exclusion Criteria:
Dementia with Lewy Bodies (DLB) Specific Criteria:
Inclusion Criteria:
Exclusion Criteria:
Frontotemporal Dementia (FTD) Specific Criteria:
Inclusion Criteria:
Exclusion Criteria:
Amyotrophic Lateral Sclerosis (ALS) Specific Criteria:
Inclusion Criteria:
Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
120 participants in 1 patient group
Loading...
Central trial contact
Junwei Hao, MD;PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal